JP Morgan Chase’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.27K Buy
+3,491
New +$4.37K ﹤0.01% 6941
2025
Q2
Sell
-66
Closed -$69 7673
2025
Q1
$69 Sell
66
-5
-7% -$6 ﹤0.01% 6924
2024
Q4
$82 Buy
+71
New +$90 ﹤0.01% 7044
2024
Q1
Sell
-103
Closed -$105 7915
2023
Q4
$105 Buy
103
+53
+106% +$53 ﹤0.01% 7118
2023
Q3
$51 Buy
50
+31
+163% +$34 ﹤0.01% 6999
2023
Q2
$23 Hold
19
﹤0.01% 6784
2023
Q1
$0 Hold
19
﹤0.01% 7247
2022
Q4
$0 Hold
19
﹤0.01% 7025
2022
Q3
$0 Buy
+19
New +$90 ﹤0.01% 6879
2021
Q3
Sell
-21
Closed 6828
2021
Q2
$0 Buy
+21
New +$406 ﹤0.01% 6629
2018
Q3
Sell
-4,242
Closed -$169K 5841
2018
Q2
$169K Buy
+4,242
New +$185K ﹤0.01% 4632
2018
Q1
Sell
-7,032
Closed -$322K 5649
2017
Q4
$322K Buy
+7,032
New +$234K ﹤0.01% 4260
2016
Q3
Sell
-35
Closed -$3K 4826
2016
Q2
$3K Buy
+35
New +$3.64K ﹤0.01% 4557
2016
Q1
Sell
-289
Closed -$41K 4962
2015
Q4
$41K Buy
+289
New +$42.3K ﹤0.01% 3953

Other funds holding VANI

JP Morgan Chase's VANI Position: Q1 2026 in Review

JP Morgan Chase opened a new position in Vivani Medical (VANI) in Q1 2026: 3,491 shares worth $3.27K. The stake represents ﹤0.01% of the portfolio and ranks #6941 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in VANI as recently as Q1 2025.

JP Morgan Chase first reported a position in VANI in Q4 2015 and has held it in 14 quarters since. The position peaked at $322K in Q4 2017. 43 funds tracked by Wall St. Rank hold VANI as of Q1 2026.

  • JP Morgan Chase held 3,491 shares of Vivani Medical worth $3.27K as of Q1 2026.
  • Vivani Medical was a new JP Morgan Chase position in Q1 2026.
  • Vivani Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6941 holding.
  • JP Morgan Chase first reported a position in Vivani Medical in Q4 2015 and has held it in 14 quarters since.
  • JP Morgan Chase's Vivani Medical position peaked at $322K in Q4 2017.
  • 43 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.